Status:
COMPLETED
Cardiovascular Intervention Improvement Telemedicine Study
Lead Sponsor:
VA Office of Research and Development
Conditions:
Cardiovascular Disease
Hypertension
Eligibility:
All Genders
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) is the leading cause of death in the United States; more than 80% of veterans have \> 2 risk factors for CVD. Our study is one of the first to examine the implementation o...
Detailed Description
Anticipated Impacts on Veteran's Healthcare: Cardiovascular disease (CVD) is the leading cause of death in the U.S.; more than 80% of veterans have \> 2 risk factors for CVD. An intervention that addr...
Eligibility Criteria
Inclusion
- Enrolled in one of three Durham Veterans Affairs Medical Center (DVAMC) Primary Care Clinics affiliated with the hospital or the Raleigh Community-Based Outpatient Clinic (CBOC) for at least one year;
- At least one visit to a primary care physician (PCP) at the Raleigh CBOC or Durham Veterans Affairs Medical Center (VAMC) associated primary care clinics in the previous 12 months;
- Outpatient diagnostic code for hypertension and/or hypercholesterolemia and lab values indicating either poorly controlled BP levels (\>150/90 Hg) AND/OR LDL (\>130mg/dl) in the previous year.
Exclusion
- diagnosed with metastatic cancer,
- diagnosed with dementia,
- active diagnosis of psychosis,
- treated with dialysis,
- most recent creatinine lab level \>2.5 or no creatinine lab value within past year
- hospitalized for a stroke, heart attack, or had surgery for blocked arteries in the past 3 months,
- participating in another interventional trial,
- not currently receiving care at the Durham VAMC or the Raleigh CBOC
- resident of a nursing home,
- hard time seeing type/printing on books, magazines articles, etc.
- hard time hearing on the telephone
- limited/no access to telephone
- plans to move medical care from DVAMC or Raleigh CBOC in next 12 months
- CVD care is currently being managed by a clinical pharmacist
- HbA1C value in the last 90day \> 10% and patient is currently not on an insulin regimen.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 22 2015
Estimated Enrollment :
428 Patients enrolled
Trial Details
Trial ID
NCT01142908
Start Date
November 1 2011
End Date
May 22 2015
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States, 27705-3875